Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization

Journal of Bone and Mineral Research

Volumn 17, Issue 5, 2002, Pages 860-868

  Adar, Rivka ^a,b   Monsonego Ornan, Efrat ^a,b   David, Pe'er ^a   Yayon, Avner ^a,b  

^a ProChon Biotech Ltd   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Dimerization; Fibroblast growth factor receptors; Receptor tyrosine kinase; Signal transduction; Skeletal dysplasia

Indexed keywords

CYSTEINE; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS;

ACHONDROPLASIA; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BONE DYSPLASIA; BONE GROWTH; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; DWARFISM; GENE MUTATION; IMMUNOPRECIPITATION; NONHUMAN; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; THANATOPHORIC DWARFISM;

EID: 0036239904     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.5.860     Document Type: Article

References (31)

1. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity
2. Structural and functional diversity in the FGF receptor multigene family
3. The FGF family of growth factors and oncogenes
4. The fibroblast growth factor family: Structural and biological properties
5. Angiogenic factors
6. Function of fibroblast growth factors and their receptors
7. Endochondral ossification in achondroplastic dwarfism
8. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I
9. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
10. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
11. Mutations in the gene encoding fibroblast growth factor, receptor-3 in achondroplasia
12. Mutations in transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, Achondroplasia
13. Hypochondroplasia: Molecular analysis of the fibroblast growth factor receptor 3 gene
14. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3
15. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation
16. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
17. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation
18. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
19. Sorting polyclonal antibodies into functionally distinct fractions using peptide phage display: 'A library on top of a library'
20. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
21. Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I
22. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. Relationship to differentiation stage
23. Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro
24. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2
25. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia
26. FGFR activation in skeletal disorders: Too much of a good thing
27. Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells
28. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation
29. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, stat activation, and phosphatidylinositol 3-kinase activation
30. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding
31. Signal transduction by fibroblast growth factor receptors